Vyxeos Liposomal: An overview of real-world evidence from five European studies

Back to resources

Key data for Vyxeos Liposomal from cohorts in England, CREST-UK, France, Italy and Germany in the context of Study 301 results.

Prescribing Information can be found at the top of this page. Adverse event reporting is available at the bottom of this page.

Topics: Real-world Data Safety Vyxeos Liposomal Data

ADVERSE EVENTS REPORTING

Adverse events should be reported. For the UK, reporting forms and information can be found at: https://yellowcard.mhra.gov.uk/

For the Republic of Ireland, reporting forms and information can be found at: https://www.hpra.ie/homepage/about-us/report-an-issue

Adverse events should also be reported to Jazz Pharmaceuticals by phone: +44 8081890387 (UK toll-free) or +353 1 968 1631 (Republic of Ireland).

UK-VYX-2300002 | February 2023